Business

Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability

WIXOM, Mich., May 07, 2026--Rockwell Medical 2026 Guidance is centered around strengthening revenue, expanding gross margin, and generating positive Adjusted EBITDA and cash flow

articleRockwell Medical, Inc.May 7, 202610/company/rockwell-medical-inc/news/rockwell-medical-announces-first-quarter-2026-results-and-additional-2026-guidance-with-focus-on-profitability
Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability

About this update from Rockwell Medical, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/business-wire.com/87d50a55e59d61bca8a46fe89d1cc948"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OhXFyi1VZgiExuSyLyf59Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNQ--/https://media.zenfs.com/en/business-wire.com/87d50a55e59d61bca8a46fe89d1cc948","width":400,"height":400},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/gX9jb5WbEd6qo.zBfITEuQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTY0MA--/https://media.zenfs.com/en/business-wire.com/87d50a55e59d61bca8a46fe89d1cc948","width":400,"height":400}},"lazy":false},{"type":"image","alt":"Rockwell Medical's Profitability Trend (2021-2026)","displaySize":"","headline":null,"caption":"Rockwell Medical's Profitability Trend (2021-2026)","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":269,"url":"https://media.zenfs.com/en/business-wire.com/30806c38a313453e6e8837885d08f5e2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/msch4PWDhRt5HvTrchY_Bw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUzOA--/https://media.zenfs.com/en/business-wire.com/30806c38a313453e6e8837885d08f5e2","width":480,"height":269},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/DJyfTbuZyevKaVFLkSRIBQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTM1OQ--/https://media.zenfs.com/en/business-wire.com/30806c38a313453e6e8837885d08f5e2","width":480,"height":269}}},{"type":"list","items":[{"val":[{"type":"text","content":"Reports $17.3 million in net sales, $2.9 million in gross profit, and 17% gross margin in the first quarter 2026.","length":113,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Announces operational changes that are expected to generate more than $3 million in additional gross profit on an annualized basis.","length":131,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"2026 guidance reflects the Company's emphasis on growth, improved gross margin, and generating positive cash flow.","length":118,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":362,"olType":false},{"type":"text","content":"WIXOM, Mich., May 07, 2026--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops,...

More updates from Rockwell Medical, Inc.

Rockwell MedicalThe CompanyEBITDA